← Leaderboards
Stephen R Salton
Icahn School Of Medicine At Mount Sinai
$16,387,402
Attributed
$26,463,477
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,463,477 · 15
By mechanism
R01$18,900,134 · 10
RF1$4,083,855 · 1
T32$2,886,238 · 2
R21$339,000 · 1
R33$254,250 · 1
Top collaborators
- Michelle E Ehrlich10 shared
- Alessandro Bartolomucci5 shared
- Christoph Buettner5 shared
- Matthew L Shapiro5 shared
- Lyudmila H Vulchanova5 shared
- Bin Zhang5 shared
- Minghui Wang1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Christoph Buettner$9,918,421
- Bin Zhang$19,809,238
- Jeremy Seth Leventhal$1,179,095
- Minghui Wang$1,519,632
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposGenesBrainProteinsPeptidesMolecularMouse ModelNeuronsBrain-Derived Neurotrophic FactorSignal TransductionPathway InteractionsRegulationNeuropeptidesPlayPhenotypeMediatingS DiseaseC-TerminalKnockout MiceAblationAdultNeurotrophic FactorBehaviorBehavioral
Grant awards (59)
Novel directions for investigating the role of VGF in comorbid Major Depressive Disorder and Alzheimer's disease$844,931
R01 · FY2025 · AG · contact PI
Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease$827,826
R01 · FY2025 · AG · contact PI
Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease$844,721
R01 · FY2024 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$842,983
R01 · FY2022 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$984,151
R01 · FY2021 · AG · contact PI
Neural mechanisms for VGF regulation of energy balance$556,723
R01 · FY2021 · DK · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$842,983
R01 · FY2020 · AG · contact PI
Neural mechanisms for VGF regulation of energy balance$556,723
R01 · FY2020 · DK · contact PI
Neural mechanisms for VGF regulation of energy balance$421,632
R01 · FY2020 · DK · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$282,334
R01 · FY2020 · AG · contact PI
VGF peptide TLQP-21, a novel microglial C3aR1 modulator in Alzheimer's disease$4,083,855
RF1 · FY2019 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$843,557
R01 · FY2019 · AG · contact PI
Neural mechanisms for VGF regulation of energy balance$556,723
R01 · FY2019 · DK · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$867,487
R01 · FY2018 · AG · contact PI
Neural mechanisms for VGF regulation of energy balance$574,098
R01 · FY2018 · DK · contact PI
Training Program in Neuroscience$181,811
T32 · FY2018 · MH · contact PI
Training Program in Neuroscience$179,737
T32 · FY2017 · MH · contact PI
Training Program in Mental Health Research$268,835
T32 · FY2016 · MH
Training Program in Neuroscience$177,715
T32 · FY2016 · MH · contact PI
VGF, critical role in the transition from acute to chronic pain$444,997
R01 · FY2015 · DE
Training Program in Mental Health Research$247,672
T32 · FY2015 · MH
Training Program in Neuroscience$175,745
T32 · FY2015 · MH · contact PI
VGF, critical role in the transition from acute to chronic pain$444,997
R01 · FY2014 · DE
VGF function in depression and antidepressant treatment$419,513
R01 · FY2014 · MH · contact PI
Training Program in Mental Health Research$262,222
T32 · FY2014 · MH
Training Program in Neuroscience$173,827
T32 · FY2014 · MH · contact PI
VGF, critical role in the transition from acute to chronic pain$503,724
R01 · FY2013 · DE
VGF function in depression and antidepressant treatment$402,732
R01 · FY2013 · MH · contact PI
Training Program in Mental Health Research$184,547
T32 · FY2013 · MH
Training Program in Neuroscience$180,562
T32 · FY2013 · MH · contact PI
VGF, critical role in the transition from acute to chronic pain$525,182
R01 · FY2012 · DE
VGF function in depression and antidepressant treatment$419,513
R01 · FY2012 · MH · contact PI
Training Program in Mental Health Research$184,598
T32 · FY2012 · MH
Training Program in Neuroscience$179,911
T32 · FY2012 · MH · contact PI
VGF, critical role in the transition from acute to chronic pain$523,986
R01 · FY2011 · DE
VGF function in depression and antidepressant treatment$419,513
R01 · FY2011 · MH · contact PI
Training Program in Neuroscience$136,174
T32 · FY2011 · MH · contact PI
VGF function in depression and antidepressant treatment$423,750
R01 · FY2010 · MH · contact PI
Human VGF Polymorphisms and Depression$254,250
R33 · FY2010 · MH · contact PI
Training Program in Neuroscience$176,882
T32 · FY2010 · MH · contact PI
Training Program in Neuroscience$176,000
T32 · FY2009 · MH · contact PI
Human VGF Polymorphisms and Depression$169,500
R21 · FY2009 · MH · contact PI
Association of 7q22.1 gene VGF with obesity and leaness$334,042
R01 · FY2008 · DK · contact PI
Human VGF Polymorphisms and Depression$169,500
R21 · FY2008 · MH · contact PI
Association of 7q22.1 gene VGF with obesity and leaness$377,749
R01 · FY2007 · DK · contact PI
Association of 7q22.1 gene VGF with obesity and leaness$331,034
R01 · FY2006 · DK · contact PI
Association of 7q22.1 gene VGF with obesity and leaness$35,976
R01 · FY2006 · DK · contact PI
Association of 7q22.1 gene VGF with obesity and leaness$339,000
R01 · FY2005 · DK
Mechanisms of neuronal hypoglycemic injury$295,215
R01 · FY2005 · NS
Association of 7q22.1 gene VGF with obesity and leaness$26,128
R01 · FY2005 · DK
VGF: A NOVEL REGULATOR OF ENERGY BALANCE$335,525
R01 · FY2004 · DK
Mechanisms of neuronal hypoglycemic injury$296,605
R01 · FY2004 · NS
VGF: A NOVEL REGULATOR OF ENERGY BALANCE$335,525
R01 · FY2003 · DK
Mechanisms of neuronal hypoglycemic injury$297,995
R01 · FY2003 · NS
VGF: A NOVEL REGULATOR OF ENERGY BALANCE$335,525
R01 · FY2002 · DK
Mechanisms of neuronal hypoglycemic injury$316,760
R01 · FY2002 · NS
VGF: A NOVEL REGULATOR OF ENERGY BALANCE$321,625
R01 · FY2001 · DK
REGULATION OF VGF BY NEUROTROPHIC GROWTH FACTORS$275,356
R01 · FY2001 · AG
REGULATION OF VGF BY NEUROTROPHIC GROWTH FACTORS$271,295
R01 · FY2000 · AG